Two systematic reviews looked at chlorella and cardiovascular risk factors and reached opposite conclusions. One, pooling 19 trials and 797 subjects, found significant drops in cholesterol, LDL and blood pressure. A second, published seven years later and restricted to a smaller trial pool, found chlorella had a neutral effect on both blood pressure and lipids. Same compound, same outcome category, different answer — which tells you something important about how thin this evidence base actually is.
Fallah's 2018 meta-analysis of 19 randomised trials (797 subjects) found chlorella significantly reduced total cholesterol (−9.09 mg/dl), LDL cholesterol (−8.32 mg/dl), systolic blood pressure (−4.51 mmHg) and fasting glucose, with the strongest effects at doses above 4 g/day for 8+ weeks. Pinto-Leite's 2025 meta-analysis, searching a different and partly overlapping trial set, found chlorella had a neutral effect on both blood pressure and lipemia, while spirulina produced a small but significant diastolic blood pressure reduction of −0.42 mmHg (95% CI −0.81 to −0.02) with no significant lipid effect. Neither alga has a documented microcystin problem in properly tested spirulina or chlorella products; the contamination risk is specific to a third species, Aphanizomenon flos-aquae, sometimes sold in blends.
So which one should you actually buy? The honest answer starts with why two meta-analyses of the same intervention landed in different places.
Why Do the Two Meta-Analyses Disagree?
Different trial pools, different populations, and a genuinely small effect size trying to survive statistical noise.
Fallah's 2018 analysis pooled 19 trials with 797 total participants and found chlorella cut total cholesterol by 9.09 mg/dl, LDL by 8.32 mg/dl, systolic blood pressure by 4.51 mmHg and diastolic by 1.64 mmHg, plus a fasting glucose drop. Subgroup analysis showed the effect concentrated in trials running 8 weeks or longer at doses above 4 g/day, and in unhealthy or hypertensive participants specifically.
Pinto-Leite's 2025 review searched independently, found 12 chlorella studies with participant counts from 168 to 279 depending on the outcome, and concluded chlorella had a neutral effect on blood pressure and lipemia. The trial sets weren't identical, the populations mixed healthy and unhealthy subjects differently, and the smaller pooled sample in some outcomes gives less power to detect a real but modest effect.
Read together, the honest position is that chlorella's cardiovascular effect, if it exists, is small enough that whether it shows up significant depends heavily on which trials get included. That's not a ringing endorsement.
What Does Spirulina Actually Do?
Less than chlorella's better-case scenario, and more precisely measured because of it.
Pinto-Leite's 2025 analysis pooled 9 spirulina trials with 101 to 299 participants depending on outcome and found a significant reduction in diastolic blood pressure of −0.42 mmHg (95% CI −0.81 to −0.02, p = 0.04). Total cholesterol trended downward (−0.17, 95% CI −0.39 to 0.06) without reaching significance.
The authors' own conclusion is worth quoting directly: the effect is real but its "magnitude is small and of uncertain clinical significance." That's an honest meta-analysis talking, and it's a useful contrast to marketing copy that treats any significant p-value as a health claim. Our spirulina benefits article covers the wider evidence, including protein and micronutrient content.
Do the Nutrient Profiles Actually Differ?
Yes, and this is where a real distinction exists rather than a marketing one.
Chlorella has a documented, unusual nutritional feature: Kumudha's 2015 analysis identified and characterised methylcobalamin — an active form of vitamin B12 — in Chlorella vulgaris, at roughly 27–30 µg per 100 g dry weight by three independent quantification methods. That matters because most plant sources marketed as containing B12 actually contain inactive analogues that don't function in humans; chlorella's B12 has been chemically confirmed as the genuine, bioactive form.
Spirulina's protein content is the more commonly cited distinguishing feature — a complete amino acid profile at a high percentage of dry weight — though whole-food protein quality claims for either alga are usually made from composition data rather than human absorption trials.
Is the Contamination Concern Real?
Partly, and it's specific rather than general. Heussner's 2012 analysis tested thirteen commercial algae products sold in Germany — spirulina, chlorella, Aphanizomenon flos-aquae, and blends — for microcystins, nodularins, saxitoxins, anatoxin-a and cylindrospermopsin.
Only the Aphanizomenon flos-aquae products tested positive for microcystins and for the mcyE gene associated with toxin synthesis, at levels up to 1 µg MC-LR equivalents per gram dry weight. None of the tested toxins appeared in the pure spirulina or chlorella products. The authors' conclusion was pointed specifically at Aph. flos-aquae, calling its commercial sale "highly questionable" — not a blanket statement about blue-green algae generally.
The practical takeaway: check the species on the label. A product labelled purely spirulina or chlorella carries a different risk profile than one blended with or substituting Aphanizomenon flos-aquae, a species this study specifically flagged.
How Do They Compare Head to Head?
| Spirulina | Chlorella | |
|---|---|---|
| Blood pressure evidence | Small significant DBP drop (−0.42 mmHg) | Contested — significant in one meta-analysis, null in another |
| Lipid evidence | Non-significant trend | Significant in Fallah 2018 at high dose/duration; null in Pinto-Leite 2025 |
| Distinctive nutrient | High complete protein content | Confirmed bioactive B12 (methylcobalamin) |
| Contamination risk (pure product) | None found in tested German market products | None found in tested German market products |
| Contamination risk (species to avoid) | Aphanizomenon flos-aquae, pure or blended | |
| Effective dose range in trials | Varies by trial | >4 g/day for 8+ weeks, per subgroup analysis |
Which One Should You Buy?
- Vegan or vegetarian and want B12? Chlorella has confirmed bioactive methylcobalamin; spirulina's B12 content is largely inactive analogue and shouldn't be relied on for that purpose.
- Chasing a blood pressure or cholesterol effect? Treat both as marginal adjuncts at best. Chlorella's own evidence disagrees with itself, and spirulina's authors describe their own significant result as of uncertain clinical significance.
- If you try chlorella for cardiovascular effect, match the dose that showed results. Fallah's subgroup data specifically requires more than 4 g/day for at least 8 weeks.
- Check the label for species. Avoid products containing Aphanizomenon flos-aquae, pure or blended — that's the species with a documented microcystin finding.
- Don't expect either to replace blood pressure or cholesterol medication. The effect sizes are a fraction of what a statin or an antihypertensive produces.
- Buy for nutrient density, not for a clinical claim. Both are legitimately dense in protein, minerals and specific compounds; that's a more defensible reason to buy either than the cardiovascular literature currently supports.
The Honest Summary
Neither alga has a settled cardiovascular effect. Chlorella's own literature contradicts itself across two meta-analyses seven years apart, and spirulina's one significant result is small enough that its own authors call its clinical significance uncertain. What's genuinely established is narrower: chlorella contains real, bioactive B12, and pure spirulina or chlorella products tested in one market survey carried no microcystin contamination, unlike a third species sometimes sold alongside them.
If you're buying either for its cardiovascular promise, size your expectations to a meta-analysis effect measured in single-digit millimetres of mercury, not a headline. If you're buying for nutrient density or B12, the case is more straightforward and doesn't need the cardiovascular story to hold up.
Frequently Asked Questions
Does chlorella lower cholesterol?
The evidence is contradictory. A 2018 meta-analysis of 19 trials found significant reductions in total cholesterol and LDL at doses above 4 g/day for 8 or more weeks; a 2025 meta-analysis using a different trial pool found chlorella had a neutral effect on lipemia.
Does spirulina lower blood pressure?
A small amount, according to a 2025 meta-analysis: diastolic blood pressure fell by 0.42 mmHg on average across 9 pooled trials. The study authors themselves describe the clinical significance of that magnitude as uncertain.
Which has more vitamin B12, spirulina or chlorella?
Chlorella has confirmed bioactive B12 as methylcobalamin, identified by mass spectrometry at roughly 27–30 µg per 100 g dry weight. Spirulina's reported B12 content is largely an inactive analogue that doesn't function as vitamin B12 in humans.
Are spirulina and chlorella contaminated with toxins?
A market study of thirteen products found no microcystins in pure spirulina or chlorella products. The species that tested positive was Aphanizomenon flos-aquae, sometimes sold alone or blended with spirulina or chlorella — checking the label for that species is the relevant precaution.
What dose of chlorella is needed for a cardiovascular effect?
Subgroup analysis in the meta-analysis that found a significant effect specifically identified doses above 4 g/day sustained for 8 weeks or longer as necessary to see reductions in cholesterol and blood pressure.
Shop Spirulina
We currently carry Spirulina powder (120 caps €29), tested for the microcystin-free profile documented in pure spirulina products. For B12 specifically, a dedicated supplement or fortified food remains the more reliable route regardless of which alga you choose. Free shipping on orders over €50.
Related Articles
- Spirulina Benefits and Nutrition
- Spirulina Dosage and Quality Guide
- Spirulina Side Effects and Contaminants
- Best Mushrooms for Stress and Cortisol
- Sea Moss vs Spirulina
- Mushroom Supplement Stacking Guide
- Heavy Metals in Mushroom Supplements
Sources
- Pinto-Leite M, Martins D, Ferreira AC, et al. The role of chlorella and spirulina as adjuvants of cardiovascular risk factor control: a systematic review and meta-analysis of randomised controlled trials. Nutrients. 2025;17(6):943. PubMed 40289965
- Fallah AA, Sarmast E, Habibian Dehkordi S, et al. Effect of chlorella supplementation on cardiovascular risk factors: a meta-analysis of randomized controlled trials. Clin Nutr. 2018;37(6 Pt A):1892-1901. PubMed 29037431
- Kumudha A, Selvakumar S, Dilshad P, Vaidyanathan G, Thakur MS, Sarada R. Methylcobalamin—a form of vitamin B12 identified and characterised in Chlorella vulgaris. Food Chem. 2015;170:316-320. PubMed 25306351
- Heussner AH, Mazija L, Fastner J, Dietrich DR. Toxin content and cytotoxicity of algal dietary supplements. Toxicol Appl Pharmacol. 2012;265(2):263-271. PubMed 23064102